Press release
Impact of Covid-19 On Non-alcoholic steatohepatitis (NASH) Market 2021 | Allergan, Cadila Healthcare Limited, Conatus Pharmaceuticals, Galmed Pharmaceuticals, Gemphire Therapeutics
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver. Scarring of the liver is a potentially life-threatening condition called cirrhosis.Growing prevalence of chronic liver conditions is expected to drive the market growth In addition, improvement in awareness of NASH in developing region is projected to supplement the market growth during the forecast period. However, side-effects and risks associated with NASH therapeutics may impede the market growth.
To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.reportsweb.com/inquiry&RW00013350768/sample
The "Global Non-Alcoholic Steatohepatitis (NASH) Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Non-Alcoholic Steatohepatitis (NASH) Market with detailed market segmentation by, drug type, sales channel, and geography. The Global Non-Alcoholic Steatohepatitis (NASH) Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-Alcoholic Steatohepatitis (NASH) Market players and offers key trends and opportunities in the market.
The Global Non-Alcoholic Steatohepatitis (NASH) Market is segmented on the basis of drug type and sales channel. Based on drug type, it is classified into vitamin E & pioglitazone, ocaliva, elafibranor, selonsertib and cenicriviroc. Based on sales channel, it is divided into hospital pharmacy, online provider and retail pharmacy.
The major manufacturers covered in this report: Allergan plc. (Tobira Therapeutics), Cadila Healthcare Limited, Conatus Pharmaceuticals Inc., Galmed Pharmaceuticals Ltd, Gemphire Therapeutics Inc., Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Novartis International AG, Shire Plc.
Scope of the report:
This research evaluates micro-markets and takes a closer look at the different growth trends, future prospects and regulations that will regulate the industry in the coming years. Researchers have also included a few top performers in the sector to calculate their industry shares and core competencies. The research explains technological developments in the sector along with upcoming areas of the industry that might potentially attract massive investments.
!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted Price@ https://www.reportsweb.com/inquiry&RW00013350768/discount
Most important Drug Type of Non-Alcoholic Steatohepatitis (NASH) covered in this report are:
• Vitamin E and Pioglitazone
• Ocaliva
• Elafibranor
• Selonsertib
• Cenicriviroc
Most important Sales Channel of Non-Alcoholic Steatohepatitis (NASH) covered in this report are:
• Hospital Pharmacy
• Online Provider
• Retail Pharmacy
Key points from Table of Content:
1.INTRODUCTION
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET LANDSCAPE
5. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET - KEY MARKET DYNAMICS
6. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET - GLOBAL MARKET ANALYSIS
7. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
8. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET - REVENUE AND FORECASTS TO 2027 - SALES CHANNEL
8.1. OVERVIEW
8.2. SALES CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital Pharmacy Market Forecast and Analysis
8.4. ONLINE PROVIDER
8.4.1. Overview
8.4.2. Online Provider Market Forecast and Analysis
8.5. RETAIL PHARMACY
8.5.1. Overview
8.5.2. Retail Pharmacy Market Forecast and Analysis
9. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10. INDUSTRY LANDSCAPE
11. NON-ALCOHOLIC STEATOHEPATITIS (NASH) MARKET, KEY COMPANY PROFILES
12. APPENDIX
Scope of the study:
• The report conducts a detailed analysis of the evolving market dynamics
• It gives a holistic view of various drivers and restraints operating in the market
• The forecast spans 6 years and predicts the prospective progress of the sector
• It categorizes the prominent product segments and their future growth scenario
• The market insights derived after a thorough investigation of the industrial segments and subsegments enable readers make informed decisions.
Interested in purchasing this Report? Click here @ https://www.reportsweb.com/buy&RW00013350768/buy/4550
Contact Us:
Name: Sameer Joshi
Email: sales@reportsweb.com
Phone: +1-646-491-9876
About ReportsWeb:
ReportsWeb is a one stop shop of market research reports and solutions to various companies across the world. We help our clients in their decision support system by assisting them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact of Covid-19 On Non-alcoholic steatohepatitis (NASH) Market 2021 | Allergan, Cadila Healthcare Limited, Conatus Pharmaceuticals, Galmed Pharmaceuticals, Gemphire Therapeutics here
News-ID: 2244323 • Views: …
More Releases from ReportsWeb
Global Security Analytics Market by 2028 covers Size, Share, Upcoming Trends Seg …
Global Security Analytics Market Analysis to 2028 is a specialized and in-depth study of the industry with a focus on the global market trend. The report aims to provide an overview of global Market with detailed market segmentation by product/application and geography. Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period.
Some of the…
Global Fuel Management System Market Analysis of Features, Benefits, Manufacturi …
Global Fuel Management System Market Analysis to 2028 is a specialized and in-depth study of the industry with a focus on the global market trend. The report aims to provide an overview of global Market with detailed market segmentation by product/application and geography. Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period.
Some of…
Global Biometric Sensor Market Size 2021 - COVID19 Impact with Top Manufacturers …
The Global Biometric Sensor Market Research Report 2020-2027 Published by Premium Market Insights, a conspicuous statistical surveying firm incorporates bits of knowledge into the market. The report has been set up by experienced and proficient market experts and scientists. They have investigated the serious scene, division, geological development, and income, creation, and utilization development of the worldwide Biometric Sensor market and included the record. Players can utilize the exact market…
Robotic Position Sensor Market Forecast, 2021–2030 | by Mechanism, Measurement …
The Global Robotic Position Sensor Market Research Report 2020-2027 Published by Premium Market Insights, a conspicuous statistical surveying firm incorporates bits of knowledge into the market. The report has been set up by experienced and proficient market experts and scientists. They have investigated the serious scene, division, geological development, and income, creation, and utilization development of the worldwide Robotic Position Sensor market and included the record. Players can utilize the…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
